Sponsor Pipeline

Xi'an Xintong Pharmaceutical Research Co.,Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07203118 A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B Chronic Hepatitis B Active, Not Recruiting
NCT07300488 Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With… HCC Active, Not Recruiting
Early Phase 1
NCT07407634 A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in… Non-Alcoholic Fatty Liver Disease Not Yet Recruiting
Disease Areas
Get alerts when Xi'an Xintong Pharmaceutical Research Co.,Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free